期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
Investigating the role of MpAL1 in drought stress responses in Malus prunifolia:insights into AL gene family functionality
1
作者 Peien Feng Jiale Li +9 位作者 Qiuying Ai Xinchu Li Jiawei Luo Yunxiao Liu Jiakai Liang Chongrong Chen Yangjun Zou Fengwang Ma Tao Zhao Yaqiang Sun 《Horticultural Plant Journal》 2026年第1期73-84,共12页
Drought stress significantly impedes apple growth,development,and yield,leading to substantial economic losses within the global apple industry.Malus prunifolia(Mp),a commonly utilized apple rootstock,has shown promis... Drought stress significantly impedes apple growth,development,and yield,leading to substantial economic losses within the global apple industry.Malus prunifolia(Mp),a commonly utilized apple rootstock,has shown promise in augmenting cultivated apple resistance to abiotic stress.Although Alfin-like(ALs)proteins have demonstrated pivotal roles in dicotyledonous plants'response to abiotic stresses,knowledge about AL genes in apple rootstocks is limited,and their functions remain largely elusive.In this study,we identified and characterized 10 MpAL gene members in the apple rootstock genome,confirming their localization within the nucleus.Our investigation revealed the significant regulation of MpALs'expression under drought and abscisic acid(ABA)stresses in M.prunifolia.In this study,one of the members,MpAL1,was selected for further exploration in Arabidopsis and apple to explore its potential function in response to drought and ABA stresses.The results showed that overexpression-MpAL1 transgenic apple calli grew significantly better than WT and MpAL1-RNAi lines,which regulates the accumulation of H_(2)O_(2)and O_(2).-levels.Additionally,transgenic Arabidopsis plants overexpressing MpAL1 exhibited positively regulating antioxidant enzymes activities under stress treatments.Further study showed that silencing MpAL1 in apple plants showed obvious chlorosis in leaves,and accumulation of reactive oxygen species under drought stress.Moreover,our detailed analysis established that MpAL1 regulates several drought and ABA-responsive genes,exerting an influence on their expression in transgenic apple.Collectively,our findings identify MpAL1 as a positive regulator that increases drought stress in apple,shedding light on its potential significance in bolstering drought resistance in this fruit crop. 展开更多
关键词 Malus prunifolia mpal1 DROUGHT Abscisic acid Transcription factor
在线阅读 下载PDF
MPAL多极子阵列声波测井在二连油田开发中的应用 被引量:4
2
作者 朱爱民 熊孝云 +2 位作者 丛培栋 田文新 陈金宏 《测井技术》 CAS CSCD 北大核心 2010年第3期293-296,共4页
MPAL多极子阵列声波测井资料可以提供地层纵波、横波、斯通利波等地质参数,为油藏勘探开发提供重要的储层信息。主要介绍了MPAL测井技术在二连油田开发中的应用效果。利用斯通利波和快慢横波开展测井精细解释;利用纵横波资料分析岩石的... MPAL多极子阵列声波测井资料可以提供地层纵波、横波、斯通利波等地质参数,为油藏勘探开发提供重要的储层信息。主要介绍了MPAL测井技术在二连油田开发中的应用效果。利用斯通利波和快慢横波开展测井精细解释;利用纵横波资料分析岩石的机械特性;利用各向异性资料判断压裂效果和窜槽以及为开发井网、钻井、完井工艺设计等提供依据,经过在二连油田4个凹陷4口井6井次的测井,取得了较好的地质工程应用效果。 展开更多
关键词 多极子阵列声波测井 各向异性 压裂 窜槽 井网 二连油田
在线阅读 下载PDF
混合表型急性白血病的预后评估及治疗选择 被引量:1
3
作者 康志杰 《医学与哲学(B)》 2018年第8期16-19,58,共5页
混合表型急性白血病(MPAL)是指在免疫学检测中,可见具有不同表型的两群以上白血病细胞,或者一种白血病细胞表达两种以上细胞的表面标志。MPAL发病率低,相关研究少,整体预后差,目前对于MPAL没有统一明确的治疗方案,因此治疗选择难度大。... 混合表型急性白血病(MPAL)是指在免疫学检测中,可见具有不同表型的两群以上白血病细胞,或者一种白血病细胞表达两种以上细胞的表面标志。MPAL发病率低,相关研究少,整体预后差,目前对于MPAL没有统一明确的治疗方案,因此治疗选择难度大。本文对MPAL的诊断流程、预后评估及治疗选择予以综述。 展开更多
关键词 急性混合表型白血病(mpal) 预后 治疗
暂未订购
缺糖缺氧对体外培养海马神经元的影响 被引量:1
4
作者 丁爱石 吴燕 +3 位作者 马子敏 李海生 吴丽颖 范明 《中国应用生理学杂志》 CAS CSCD 北大核心 2003年第4期313-317,共5页
目的 :观察缺糖缺氧诱导的培养海马神经元损伤。方法 :取培养 12d的海马神经元 ,在缺糖缺氧条件下分别培养 0 .5~ 4h后取出 ,换原神经元培养液在常氧条件下继续培养 2 4h。用 0 .4%台盼蓝染色 ,检测神经元坏死 ,并用TUNEL法检测神经元... 目的 :观察缺糖缺氧诱导的培养海马神经元损伤。方法 :取培养 12d的海马神经元 ,在缺糖缺氧条件下分别培养 0 .5~ 4h后取出 ,换原神经元培养液在常氧条件下继续培养 2 4h。用 0 .4%台盼蓝染色 ,检测神经元坏死 ,并用TUNEL法检测神经元凋亡 ,计算存活、坏死和凋亡神经元所占百分率。同时用图像分析仪测定存活、坏死和凋亡神经元的胞体面积、周长和等园直径。结果 :培养的海马神经元急性缺糖缺氧后 0 .5~ 4h ,随缺糖缺氧时间的延长 ,坏死神经元逐渐增多 ,缺糖缺氧后 0 .5~ 2h再恢复糖和氧供应后 2 4h ,凋亡神经元明显增多。图像分析的结果表明 ,坏死神经元的胞体面积、周长和等园直径均明显大于凋亡神经元。结论 :缺糖缺氧可引起海马神经元严重损伤 ,在急性缺糖缺氧后 0 .5~ 4h引起的神经元死亡以坏死为多见 ,但在缺糖缺氧后 0 .5~ 2h再恢复糖和氧供应后2 4。 展开更多
关键词 缺糖 缺氧 海马神经元 坏死 凋亡 图像分析 脑缺血
暂未订购
B淋系/髓系混合表型急性白血病伴TEL-ABL1融合基因表达1例 被引量:1
5
作者 王露婷 陆丽娜 +3 位作者 何大保 刘小敏 曹淑雅 王素云 《复旦学报(医学版)》 CAS CSCD 北大核心 2022年第4期628-632,共5页
混合表型急性白血病(mixed phenotype acute leukemia,MPAL)临床罕见,约占急性白血病的2%~5%。TEL-ABL1融合基因阳性主要见于急性髓细胞白血病(acute myeloid leukemia,AML)、急性淋巴细胞白血病(acute lymphocytic leukemia,ALL)、骨... 混合表型急性白血病(mixed phenotype acute leukemia,MPAL)临床罕见,约占急性白血病的2%~5%。TEL-ABL1融合基因阳性主要见于急性髓细胞白血病(acute myeloid leukemia,AML)、急性淋巴细胞白血病(acute lymphocytic leukemia,ALL)、骨髓增殖性肿瘤(myeloproliferative neoplasm,MPN)等恶性血液系统肿瘤,目前以病例报道为主,均提示预后不良。本例患者B淋系/髓系MPAL伴TEL-ABL1融合基因阳性为首次报道,我们给予针对淋系、髓系白血病化学治疗及酪氨酸激酶抑制剂靶向治疗后,达到完全缓解,经巩固化疗后进行人类白细胞抗原(human leucocyte antigen,HLA)相合同胞间异基因外周血造血干细胞移植,患者后因肠道排异反应死亡。 展开更多
关键词 B淋系/髓系 混合表型急性白血病(mpal) TEL-ABL1
暂未订购
A Biphenotypic (Mixed Phenotypic) Acute Leukemia: Report of Two Cases with Immunophenotypic Study
6
作者 Anupam Sarma Jagannath Dev Sharma +2 位作者 Chidananda Bhuyan Munlima Hazarika Amal Chandra Kataki 《Open Journal of Blood Diseases》 2013年第2期65-68,共4页
Biphenotypic acute leukemia (BAL) is an uncommon clinical entity. It is a type of acute leukemia with features characteristic of both the myeloid and lymphoid lineages and for this reason is designated as mixed-lineag... Biphenotypic acute leukemia (BAL) is an uncommon clinical entity. It is a type of acute leukemia with features characteristic of both the myeloid and lymphoid lineages and for this reason is designated as mixed-lineage, hybrid or biphenotypic acute leukemia. As strict diagnostic criteria have only recently been established, the precise incidence among acute leukemia is uncertain, although it is likely to account for approximately less then 5% of all acute leukemia. BAL is now collectively considered as “mixed phenotype acute leukemia” (MPAL). We hereby report two cases of a rare disease, BAL from our institution in the light of morphology, cytochemistry, flow cytometry and review of literature regarding these cases are described. 展开更多
关键词 Biphenotypic ACUTE LEUKAEMIA (BAL) MIXED Phenotype ACUTE Leukemia (mpal) Flow CYTOMETRY CYTOCHEMISTRY
暂未订购
急性混合细胞白血病伴BCR/ABL融合基因阳性的临床分析 被引量:2
7
作者 蔡静 何川 《西部医学》 2011年第7期1276-1277,共2页
目的分析伴BCR/ABL融合基因阳性的急性混合细胞白血病(MPAL)临床特点、生物学特性、临床疗效及预后。方法对1例伴BCR/ABL融合基因阳性的MPAL患者临床及实验室资料进行分析,结合细胞形态学、免疫分型及融合基因定性检测进行诊断,并予以... 目的分析伴BCR/ABL融合基因阳性的急性混合细胞白血病(MPAL)临床特点、生物学特性、临床疗效及预后。方法对1例伴BCR/ABL融合基因阳性的MPAL患者临床及实验室资料进行分析,结合细胞形态学、免疫分型及融合基因定性检测进行诊断,并予以多次不同化疗方案治疗。结果患者在治疗期间反复出现严重肺部感染,最终死于多脏器衰竭。结论 MPAL病例罕见,且无统一的治疗方案,预后差。年龄和Ph染色体阳性与患者预后紧密相关。 展开更多
关键词 BCR/ABL融合基因 PH染色体 急性混合细胞白血病
暂未订购
Safety and efficacy of mitoxantrone liposome combined chemotherapy in the treatment of mixed phenotype acute leukemia
8
作者 JIANG Huiwen 《China Medical Abstracts(Internal Medicine)》 2025年第2期123-123,共1页
Objective To evaluate the safety and efficacy of mitoxantrone liposome(MIT-LIP)combined chemotherapy in treating mixed phenotype acute leukemia(MPAL).Methods December 2021 to November 2024,MPAL patients who underwent ... Objective To evaluate the safety and efficacy of mitoxantrone liposome(MIT-LIP)combined chemotherapy in treating mixed phenotype acute leukemia(MPAL).Methods December 2021 to November 2024,MPAL patients who underwent the MAED(MIT-LIP+cytarabine+etoposide+dexamethasone)regimen were retrospectively analyzed.Data on clinical characteristics,adverse reactions,therapeutic outcomes,and long-term prognoses were collected.Results A total of 7 MPAL patients who received MAED regimen were admitted.Among them,two patients were initially diagnosed with T-ALL or BALL,respectively,and transformed into AML after treatment.Three patients were initially diagnosed as MPAL(B/myeloid),one as MPAL(T/myeloid),and one with MPAL(myeloid/plasmacytoid dendritic cell).Among the 7 patients,there were 3 males and 4 females,1 chromosome abnormalities and 6 gene abnormalities,including 1 case with BCR::ABL fusion gene.The median age was 38 years(range:16-58 years).There was no clear related drug allergy and organ toxicity during MAED regimen,and the main adverse effect was hematological toxicity.After induced chemotherapy,all patientsachieved complete remission(CR),2 maintained MRD-negative CR and 1 maintained MRDpositive CR.The other 4 patients underwent allogeneic hematopoietic stem cell transplantation,2 maintained MRD-negative CR,and 2 relapsed.The current median follow-up time was 12 months,the overall survival(OS)rate was 100%,the relapse-free survival(RFS)rate was 60%,and the median OS time and median RFS time were not reached.Conclusion The MAEDDregimen demonstrates high safety and a favorable CR rate in MPAL treatment. 展开更多
关键词 Chemotherapy Maed Regimen Clinical Characteristics mixed phenotype acute leukemia mpal methods Mitoxantrone Liposome Mixed Phenotype Acute Leukemia EFFICACY mitoxantrone liposome mit lip combined
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部